SEC Form 4 · accession 0001493152-18-010240
Provention Bio, Inc. · PRVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wayne Pisano
Director
Period of report
Jul 19, 2018
Accepted (ET)
Jul 19, 2018 · 5:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001695357
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | Jul 19, 2018 | P | 2,500 | $4.00 | A | 2,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F3,F2 | $4.00 | Jul 19, 2018 | A | 128,981 | A | — | Jul 19, 2028 | Common Stock, par value $0.0001 | 128,981 | 128,981 | D |
Explanation of responses
- F1The securities were purchased pursuant to an underwritten public offering by the Issuer. The offering closed on July 19, 2018.
- F2The option vests in eight equal semi-annual installments commencing on January 19, 2018 and will become fully vested on July 19, 2022.
- F3The securities were granted pursuant to the Issuer's 2017 Equity Incentive Plan, effective as of the closing of the Issuer's initial public offering of common stock.